Claims Against Generic Drug Maker are Not Preempted, Judge Rules



DOCUMENTS
  • Order


CHARLOTTE, N.C. - State law failure-to-warn claims brought against the manufacturer of a generic form of Reglan are not preempted by federal law because they do not rely upon the federal Food Drug and Cosmetic Act, a North Carolina federal judge has ruled. Couick v. Wyeth Inc., No. 09-210 (W.D. N.C.).

On Dec. 10, Chief Judge Robert J. Conrad Jr. of the U.S. District Court for the Western District of North Carolina further ruled that the manufacturer was not prohibited by federal law from warning customers of the dangers of long-term use of metoclopramide by means other than a Changes …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Hotel Details in Tucson, Arizona, to be Announced

MORE DETAILS